Study on the risk and countermeasure of prescription drugs sold online by drug retail enterprises
- VernacularTitle:药品零售企业网售处方药风险及对策研究
- Author:
Nengjin SHI
1
;
Jing DING
1
;
Gang WANG
2
;
Weijiang HU
3
;
Bei WANG
4
;
Min YU
5
Author Information
1. School of Pharmaceutical Business，Zhejiang Pharmaceutical Vocational University，Zhejiang Ningbo 315500，China
2. Dept. of Pharmacy，Hangzhou First People’s Hospital Affiliated to Zhejiang University School of Medicine，Hangzhou 310006，China
3. Hangzhou Drug Inspection Center，Hangzhou 310004，China
4. SPN Ningbo Pharmaceutical Co.，Ltd.，Zhejiang Ningbo 315000，China
5. East China Pharmaceutical Supply Chain Management （Hangzhou） Co.，Ltd.，Hangzhou 310018，China
- Publication Type:Journal Article
- Keywords:
drug retail enterprises;
prescription drugs sold online;
risk;
regulation;
monomers;
chain
- From:
China Pharmacy
2023;34(9):1031-1037
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To analyze the risks of prescription drugs sold online by drug retail enterprises， and to provide countermeasures and suggestions for risk prevention and control of prescription drugs sold online. METHODS The risk hierarchy structure model of prescription drugs sold online by drug retail enterprises was constructed by using analytic hierarchy process. Multiple rounds of risk research and judgment were carried out on 123 pairs of evaluation indicators by using Delphi expert survey method. The normalized weight calculation and consistency test of risk judgment matrix were carried out to perform fuzzy quantitative research. RESULTS The risk of prescription dispensing and review （6.48%）， the risk of drug first and prescription later （5.48%）， the risk of rational drug use guidance （4.99%）， the risk of buying drugs by abnormal channel （4.97%）， the risk of “first diagnosis， non-chronic disease and non-common disease” （4.43%）， and the quality and safety risk of returned drugs （4.34%） and the application risk of regulatory technology （4.06%） were high risks； the overall risk of drug retail enterprises （chain） selling prescription drugs online was 38.67%， and the overall risk of drug retail enterprises （individual） selling prescription drugs online was 61.33%， with a difference of 22.66% between them. CONCLUSIONS There were 7 high-risk indicators for prescription drugs sold online by drug retail enterprises. Among them， the risk of prescription dispensing and review， the risk of drug first and prescription later， and the risk of rational drug use guidance are the top three high-risk points. The risk of prescription drugs sold online by drug retail enterprises （individual） is higher than that of drug retail enterprises （chain）. It is recommended that regulatory authorities focus on and regulate the prescription drugs sold online by drug retail enterprises （individual）， and encourage drug retail enterprises （chain） to establish a systematic online sales process for prescription drugs； for high-risk points of prescription drugs sold online， it is recommended that regulatory authorities and drug retail enterprises focus on it and take effective risk prevention and control measures to ensure the safe use of prescription drugs by the general public.
